DiaMedica Therapeutics Inc. (DMAC) Earnings Per Share (EPS)
DiaMedica Therapeutics Inc. (DMAC) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$0.78 |
| 2021-12-31 | -$0.65 |
| 2022-12-31 | -$0.52 |
| 2023-12-31 | -$0.60 |
| 2024-12-31 | -$0.60 |
| 2025-12-31 | -$0.70 |
How DMAC compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| STIM | Neuronetics Inc. | -$0.59 |
| GOSS | Gossamer Bio Inc. | -$0.75 |
| EOLS | Evolus Inc. | -$0.80 |
| NEO | NeoGenomics Inc. | -$0.84 |
These are five companies in the same sector as DMAC with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("DMAC")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DMAC | $6.65 | -1.48% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |